Home » Newsletters » BioWorld Science

BioWorld Science

March 2, 2000

View Archived Issues

Ixion receives SBIR grant for oxalate degradation research

Acadia identifies novel mechanism of action for antipsychotics

FDA approves Androgel for treatment of hypogonadism

Myogen and UT Southwestern Medical Center collaborate on heart failure treatment

Elan's NDA for ziconotide accepted for filing

C5 inhibitor from Alexion granted fast track status for kidney disease

Human Genome Sciences and CAT to collaborate on antibody development program

Hepatitis C vaccine candidate identified by Epimmune

VEGF-targeted antisense oligonucleotides inhibit tumor growth

Effects of homocysteine lowering with vitamins on subclinical atherosclerosis

New macrolide antibiotics effective against Gram-positive microorganisms

Nonimmunosuppressive immunophilin-binding neurotrophic compounds designed at Pfizer

U.K.'s MCA approves another new meningitis C vaccine

EGF-genistein: a new pharmacological approach to treating, preventing restenosis

SB discloses production and use of Scrp-5 polypeptides/polynucleotides

Aptosyn/Gemzar cancer trials to begin shortly

Steroidogenesis Inhibitors seeks South African partner to assist in development of AIDS drug

Antitumor immunity induced by elemene involves enhancement of HSP70 expression

Successful clinical results with IDEA's drug delivery system trigger payment from P&G

Feasibility of HSV-TK/GCV gene therapy demonstrated in glioblastoma multiforme

FDA puts VEGF-2 trials on hold

Pharmacyclics initiates phase I clinical trial of Antrin for treatment of coronary artery disease

ISIS-14803 begins phase I/II evaluation as HCV treatment

Potential role for perillyl alcohol in cardiovascular disease

Alocril now available in U.S. for itch associated with allergic conjunctivitis

Several new approvals obtained for Gliadel

Maxygen enters CRADA with NCI for anticancer proteins

Biopure's oxygen therapeutic restores brain oxygenation after hemorrhagic shock

Neutralase effectively reverses new anticoagulants

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...